1-6 of 6
Hans van Eenennaam
Close
Sort by
Journal Articles

Preclinical Development of AT1412, a Patient Derived CD9 Antibody That Does Not Induce Thrombosis for Treatment of B ALL

Remko Schotte, Julien Villaudy, PhD, Greta De Jong, MD, Viviana Neviani, PhD, Wouter Pos, PhD, Sophie E Levie, Daniel M Go, Etsuko Yasuda, PhD, Esmay Frankin, Madalina Cercel, Susan E van Hal-van Veen, Dorien van de Berg, Anikó Szabó, MD, Christien Fatmawati, Martijn Kedde, PhD, Yvonne Claassen, Sjeng Horbach, PhD, Anita W Rijneveld, MD PhD, Piet Gros, prof, Hergen Spits, prof, Mette D Hazenberg, MD PhD, Hans van Eenennaam, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 41–42.
https://doi.org/10.1182/blood-2020-134088
Published: 2020
Journal Articles

AT1412, a Patient-Derived Antibody in Development for the Treatment of CD9 Positive Precursor B-Acute Lymphoblastic Leukemia

Greta De Jong, Sophie E Levie, Remko Schotte, PhD, Wouter Pos, PhD, Daniel Go, Etsuko Yasuda, Madalina Cercel, Susan E van Hal-van Veen, Esmay Frankin, Anikó Szabó, MD, Julien Villaudy, PhD, Pauline M van Helden, PhD, Hans van Eenennaam, PhD, Hergen Spits, PhD, Anita W Rijneveld, MD PhD, Mette D Hazenberg, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4461.
https://doi.org/10.1182/blood-2019-127894
Published: 2019
Journal Articles

APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment

Yu-Tzu Tai, Chirag Acharya, Gang An, Michele Moschetta, Mike Y. Zhong, Xiaoyan Feng, Michele Cea, Antonia Cagnetta, Kenneth Wen, Hans van Eenennaam, Andrea van Elsas, Lugui Qiu, Paul Richardson, Nikhil Munshi, Kenneth C. Anderson
Journal: Blood
Blood (2016) 127 (25): 3225–3236.
https://doi.org/10.1182/blood-2016-01-691162
Published: 2016
Includes: Supplemental data
Journal Articles

APRIL/B Cell Maturation Antigen (BCMA) Signaling Cascades Promote Human Multiple Myeloma Growth and Mediate Immunosuppression in the Bone Marrow Microenvironment Via IL-10, TGF-b, and PD-L1

Yu-Tzu Tai, PhD, Chirag Acharya, MD, Gang An, MDPhD, Michele Moschetta, MD, Mike Zhong, BS, Xiaoyan Feng, MD, Hans van Eenennaam, PhD, Andrea van Elsas, PhD, Lugui Qiu, MD PhD, Nikhil C. Munshi, MD, Kenneth C Anderson, MD
Journal: Blood
Blood (2015) 126 (23): 1810.
https://doi.org/10.1182/blood.V126.23.1810.1810
Published: 2015
Journal Articles

A Novel Anti-a Proliferation-Inducing Ligand Hapril.01A Monoclonal Antibody Targets Multiple Myeloma Cells in the Bone Marrow Microenvironment

Yu-Tzu Tai, PhD, Chirag Acharya, MD, Gang An, MD PhD, Mike Y Zhong, Michele Cea, MD, Antonia Cagnetta, MD, Hua Jiang, MDPhD, Hans van Eenennaam, PhD, Andrea van Elsas, PhD, Nikhil C. Munshi, MD, Kenneth C. Anderson
Journal: Blood
Blood (2014) 124 (21): 2098.
https://doi.org/10.1182/blood.V124.21.2098.2098
Published: 2014
Journal Articles

Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas

Marco Guadagnoli, Fiona C. Kimberley, Uyen Phan, Katherine Cameron, Paul M. Vink, Hans Rodermond, Eric Eldering, Arnon P. Kater, Hans van Eenennaam, Jan Paul Medema
Journal: Blood
Blood (2011) 117 (25): 6856–6865.
https://doi.org/10.1182/blood-2011-01-330852
Published: 2011
Includes: Supplemental data